Comparison of Clinical Outcomes between Twice- and Thrice- Weekly Hemodialysis in Thai Elderly Patients at Bhumirajanakarindra Kidney Institute Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20171231003

Enrollment

200

Registered

2017-12-31

Start date

2018-03-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage kidney disease Receiving twice or thrice weekly hemodialysis hemodialysis, elderly, incremental dialysis, kidney failure, end stage kidney disease

Interventions

ESRD patients aged 65 years or older receiving twice weekly hemodialysis at Bhumirajanakarindra Kidney Institute Hospital,ESRD patients aged 65 years or older receiving twice weekly hemodialysis at Bh

Treatment,Treatment

Twice weekly hemodialysis,Thrice weekly hemodialysis

Eligibility

Sex/Gender

All

Age

65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age 65 years or older 2. Have been diagnosed with end stage renal disease 3. Receving twice or thrice weekly hemodialysis regularly at Bhumirajanakarindra Kidney Institute Hospital at least 3 months before enrollment 3. Signed written informed consent approved by the Ethical Review Committee for Research in Human Subjects, Ministry of Public Health

Exclusion criteria

Exclusion criteria: History of previous peritoneal dialysis or kidney transplantation Patients who did not give written informed consent.

Design outcomes

Primary

Measure	Time frame
composite end points of all-cause mortality, cardiovascular events, hospitalization from any cause 36 months rate/patient-year	—

Secondary

Measure	Time frame
All-cause mortality 36 months rate/patient-year,Death from cardiovascular cause 36 months rate/patient-year,Cardiovascular events 36 months rate/patient-year,Hospitalization from any infection 36 months rate/patient-year,Hospitalization from cardiovascular events 36 months rate/patient-year,Health related quality of life every 6 months KDQOL-36 score (Thai version),Caregiver burden every 6 months Scale by Zarit Burden Interview (Thai version),Residual renal function every 6 months Kr (ml/min/1.73m2), urine volume (ml),Adequacy of hemodialysis every 6 months stdKt/V per week,Nutritional status every 6 months nPCR, serum albumin (g/dL),Markers of metabolic bone disease every 6 months Serum calcium (mg/dL), phosphate (mg/dL), parathyroid hormone (pg/mL),Anemia every 6 months Hb (g/dL), ESA dose (units/week),Vascular access complication 36 months rate/patient-year,Vascular access complication 36 months rate/patient-year	—

Measure

Time frame

All-cause mortality 36 months rate/patient-year,Death from cardiovascular cause 36 months rate/patient-year,Cardiovascular events 36 months rate/patient-year,Hospitalization from any infection 36 months rate/patient-year,Hospitalization from cardiovascular events 36 months rate/patient-year,Health related quality of life every 6 months KDQOL-36 score (Thai version),Caregiver burden every 6 months Scale by Zarit Burden Interview (Thai version),Residual renal function every 6 months Kr (ml/min/1.73m2), urine volume (ml),Adequacy of hemodialysis every 6 months stdKt/V per week,Nutritional status every 6 months nPCR, serum albumin (g/dL),Markers of metabolic bone disease every 6 months Serum calcium (mg/dL), phosphate (mg/dL), parathyroid hormone (pg/mL),Anemia every 6 months Hb (g/dL), ESA dose (units/week),Vascular access complication 36 months rate/patient-year,Vascular access complication 36 months rate/patient-year

—

Countries

Thailand

Contacts

Public ContactPrapa Pattrapornpisut

Bhumirajanakarindra Kidney Institute Hospital

prapa.pattraporn@gmail.com0870495327

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026